TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07219771: A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients (MOTION-P)

Sponsor: Doron Therapeutics Inc. · Phase: PHASE3 · Area: IMMUNOLOGY · Target Enrollment: 300 pts

Competing Trials Overlap

12 Active Trials

Excess Burn Exposure

$3,233,340

Rescue Site Savings

+$2,155,560

Unlock Full NCT07219771 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07219771 Rescue Dossier →